← Back to all trials
Completed
NCT03357185
Prospective Evaluation of Femoral Tripod Eversion Technique
Conditions: Atheromatous
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 37
Sponsor: Hôpital NOVO
Location: Hôpital NOVO Cergy-Pontoise
Summary
Endarteriectomy is considered as the first line treatment of femoral bifurcation atheromatous lesions. Eversion technique, similar to that used for carotid bifurcation, is safe and possible for the majority of the femoral tripod lesions. The major advantage of the eversion technique is the absence of prosthetic material to be performed. However, its use has been scarcely evaluated in the literature to date. This work aims at evaluating the long term safety and the efficacy of eversion femoral technique. Surgical technique was thoroughly described and participants were followed up for two years by serial clinical and doppler US examination.
Eligibility Criteria
Inclusion Criteria:
* Age\>18 years
* Lower limb atheromatous occlusive disease.
* Stage 2 to 4 according to Rutherford's classification
Exclusion Criteria:
* Age\< 18
* Previous surgery or endovascular treatment of the ipsilateral limb
* Non atheromatous disease
* Pregnancy
* Life-expectancy estimated to be less than one year
Source: ClinicalTrials.gov (NCT03357185). StuddyBuddy aggregates publicly available trial information.